PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Secure product digitalization with gambling features

The approach taken in the development of this innovative anti-cloning security seal was that product verification should offer entertainment value as part of the...
Continue Reading →
News

FDA approves single-vial version of GSK’s Menveo vaccine, ending need for reconstitution

GSK has won FDA approval for a single-vial formulation of its meningococcal disease vaccine Menveo, thereby ending the need for reconstitution that has existed since...
Continue Reading →
News

Roche recalls new eye therapy Susvimo on leakage fears, aims for market return ‘within a year or so’

Just as doctors were starting to cozy up to Roche and Genentech’s new eye drug delivery therapy, the companies are pulling the product from U.S. shelves. Roche ha...
Continue Reading →
News

Love Pharma moves to buy transdermal opioid-use disorder player

Love Pharma has struck a deal to acquire transdermal drug delivery technology, signing a letter of intent to buy Naltrexone Therapeutics for intellectual property co...
Continue Reading →
News

Bankrupt Zosano sells intradermal delivery tech to Emergex Vaccines

The unraveling of Zosano Pharma has led to a drug delivery deal. With the company filing for bankruptcy in the wake of its rejection by the FDA, Emergex Vaccines has...
Continue Reading →
News

Surge raises $26M to take anti-cancer extended-release hydrogel into the clinic

Surge Therapeutics has raised money to take its extended-release biodegradable hydrogel into the clinic, reeling in $26 million to test its belief that implanting th...
Continue Reading →
News

Positive results from trial of Arecor’s insulin candidate AT247

Therapy demonstrates significantly accelerated insulin absorption and early exposure. Arecor has announced headline results from the second phase 1 clinical trial...
Continue Reading →
News

AlzeCure demonstrates disease-modifying effects of NeuroRestore ACD856

Data from the study shows that ACD856 has a potential neuroprotective effect in a cellular mode. AlzeCure – a company that develops a broad portfolio of small mol...
Continue Reading →
News

Brainomix in collaboration with UK Government-funded NCIMI

The partnership will evaluate AI-powered technology in lung cancer care. Brainomix – the AI-powered medtech solutions company – has announced its collaboration wi...
Continue Reading →
News

ChargePoint Technology collaborates with STERIS to deliver sterile solution success for Evonik

The powder and liquid transfer specialist,  ChargePoint Technology Group, and leading provider of infection prevention and other procedural products and service...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026